BRCA1

1JM7, 1JNX, 1N5O, 1OQA, 1T15, 1T29, 1T2U, 1T2V, 1Y98, 2ING, 3COJ, 3K0H, 3K0K, 3K15, 3PXA, 3PXB, 3PXC, 3PXD, 3PXE, 4IFI, 4IGK, 4JLU, 4OFB, 4U4A, 4Y18, 4Y2G

BRCA1
BRCA1
Strwythurau
PDBHuman UniProt search: PDBe RCSB
Dynodwyr
CyfenwauBRCA1, breast cancer 1, early onset, BRCAI, BRCC1, BROVCA1, IRIS, PNCA4, PPP1R53, PSCP, RNF53, FANCS, breast cancer 1, DNA repair associated, BRCA1 DNA repair associated, Genes
Dynodwyr allanolOMIM: 113705 HomoloGene: 5276 GeneCards: BRCA1
EC number2.3.2.27
Patrwm RNA pattern


Rhagor o gyfeiriadau
Orthologau
SpeciesBod dynolLlygoden
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

RefSeq (protein)

NP_009225
NP_009228
NP_009229
NP_009230
NP_009231

n/a

Lleoliad (UCSC)n/an/a
PubMed search[1]n/a
Wicidata
Gweld/Golygu Bod dynol

Protein sydd yn cael eu codio yn y corff dynol gan y genyn BRCA1 yw BRCA1 a elwir hefyd yn breast cancer 1 (Saesneg). Segment o DNA yw'r genyn, sy'n amgodio ffwythiant arbennig. Mae'r genyn yma wedi eu lleoli ar yr edefyn ôl o gromosom dynol 17, band 17q21.31.

Cyfystyron

Yn aml mae gan enynnau lawer o gyfystyron. Mae hyn oherwydd eu bod yn aml yn cael eu darganfod gan nifer o bobl mewn cyd-destunau gwahanol heb wybod mae'r un genyn oedd hi. Hefyd Mae gan wahanol gymunedau gwyddonol safonau gwahanol ar gyfer enwi genynnau. Dyma restr o gyfystyron ar gyfer y genyn BRCA1.

  • IRIS
  • PSCP
  • BRCAI
  • BRCC1
  • FANCS
  • PNCA4
  • RNF53
  • BROVCA1
  • PPP1R53

Llyfryddiaeth

  • "Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.". PLoS One. 2017. PMID 29244844.
  • "Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.". Nat Genet. 2017. PMID 29058716.
  • "Ovarian Aging in Women With BRCA Germline Mutations.". J Clin Endocrinol Metab. 2017. PMID 28938488.
  • "Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe.". Int J Cancer. 2018. PMID 28857155.
  • "Rapid selection of BRCA1-proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers.". Cancer Lett. 2017. PMID 28377179.

Cyfeiriadau

  1. "Human PubMed Reference:".

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.